Kay Ohlendieck

Title: Kay Ohlendieck: Innovator in Muscular Dystrophy Research

Introduction

Kay Ohlendieck is a prominent inventor based in Iowa City, IA (US). She has made significant contributions to the field of muscular dystrophy research. With a total of 2 patents, her work focuses on the dystrophin-glycoprotein complex in mammalian skeletal muscle.

Latest Patents

Ohlendieck's latest patents include innovative methods for measuring non-dystrophin proteins and diagnosing muscular dystrophy. The invention pertains to the dystrophin-glycoprotein complex and a method of isolating this complex. The components of the complex and methods for separating and isolating these components are also part of her invention. Furthermore, the invention relates to a method of diagnosing muscular dystrophy by detecting and quantifying the loss of a non-dystrophin component of the dystrophin-glycoprotein complex, with this loss being indicative of muscular dystrophy.

Career Highlights

Kay Ohlendieck is affiliated with the University of Iowa Research Foundation, where she continues her groundbreaking research. Her work has garnered attention for its potential impact on diagnosing and understanding muscular dystrophy.

Collaborations

Ohlendieck has collaborated with notable colleagues, including James M. Ervasti and Mitchell G. Gaver. These collaborations have further enriched her research and contributed to advancements in the field.

Conclusion

Kay Ohlendieck is a trailblazer in the realm of muscular dystrophy research, with her innovative patents paving the way for improved diagnostic methods. Her contributions are vital to the ongoing fight against this debilitating condition.